Celldex Therapeutics | CLDX - Przychody Ze Sprzedaży





Obroty Zmiana Data
AbbVie USD 16.99B 1.99B 2026-06
Agenus USD 33.7M 500K 2026-03
Amgen USD 8.62B 1.28B 2026-03
Bristol-Myers Squibb USD 12.97B 1.48B 2026-06
Celldex Therapeutics USD 15K 106K 2026-03
Glaxosmithkline GBP 10.09B 1.37B 2026-03
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Northwest Biotherapeutics USD 200K 245K 2025-09
Pfizer USD 14.5B 3.08B 2026-03
Rigel Pharmaceuticals USD 55.31M 18.47M 2024-09
Roche Holding CHF 30.36B 14.71B 2026-06